Company intelligence / Profile preview

SEED Biosciences

Lausanne, Vaud, Switzerlandseedbiosciences.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

SEED Biosciences has developed and commercialized award-winning single-cell dispensing technologies that enable fast, gentle isolation of individual cells with high assurance of monoclonality. Their products are designed to meet stringent regulatory requirements for GMP manufacturing and are used in a variety of life science applications including biologics production and cell therapy development

Therapeutic areas: Other
Modalities: Device
Industry: Non-Drug Biotech

Partnerships

Not explicitly listed; collaborations with academic labs at EPFL noted

Beyond the preview

Go deeper on SEED Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEED Biosciences.

Explore the full profile